Lu G, Ou S
Department of Medicine, Xiangya Hospital, Hunan Medical University, Changsha.
Hunan Yi Ke Da Xue Xue Bao. 1997;22(1):66-8.
The erythrocytic activity membrane ATPases, intraerythrocytic calcium concentration ([Ca2+]i), plasma renin activity (PRA), and angiotensin II (AT-II) in 18 essential hypertensive patients (EH) and matched normal controls were determined. In the EH group, Na(+)-K(+)-ATPase, Ca(2+)-ATPase, PRA were much lower than those in the controls, and [Ca2+]i, AT-II were higher. When blood pressure was become normotensive after a course of taking nifedipine therapy, the forementioned parameter alteration restored to approach the normal range, the changes were significnt. [Ca2+]i was positively correlated with MAP, and negatively correlated with PRA and AT-II. The results suggest that the increase erythrocytic membrane ATPase activity and decrease in renin-angiotensin system activity in nifedipine treatment may be another important antihypertensive mechanism besides accompanied with the rectifying of abnormal cellular calcium metabolism.
测定了18例原发性高血压患者(EH)及相匹配的正常对照者的红细胞活性膜ATP酶、红细胞内钙浓度([Ca2+]i)、血浆肾素活性(PRA)和血管紧张素II(AT-II)。EH组中,Na(+)-K(+)-ATP酶、Ca(2+)-ATP酶、PRA均显著低于对照组,而[Ca2+]i、AT-II则较高。硝苯地平治疗一个疗程后血压恢复正常时,上述参数变化恢复并接近正常范围,差异有统计学意义。[Ca2+]i与平均动脉压(MAP)呈正相关,与PRA和AT-II呈负相关。结果提示,硝苯地平治疗使红细胞膜ATP酶活性增加及肾素-血管紧张素系统活性降低,可能是除纠正细胞钙代谢异常外的另一重要降压机制。